Year archive

MYND Life Sciences Inc. — 2022 filings

All 15 regulatory filings released by MYND Life Sciences Inc. (MYND) in 2022, sourced directly from the official regulator.

15 Filings

2022 Period

2022 filings (15)

Filing	Released	Lang
Interim MD&A - English.pdf Regulatory Filings	2022-06-23	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-06-23	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2022-06-23	English
Interim financial statements/report – English.pdf Regulatory Filings	2022-06-23	English
News release - English.pdf Regulatory Filings	2022-06-17	English
News release - English.pdf M&A Activity	2022-03-16	English
Annual MD&A - English.pdf Management Reports	2022-03-01	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2022-03-01	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2022-03-01	English
Audited annual financial statements – English.pdf Annual Report	2022-03-01	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2022-03-01	English
NI 44-101 Withdrawal Notice – English.pdf Capital/Financing Update	2022-02-28	English
Material change report - English.pdf Regulatory Filings	2022-02-16	English
News release - English.pdf Capital/Financing Update	2022-02-08	English
News release - English.pdf Regulatory Filings	2022-02-08	English